[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"pityriasis-versicolor\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:pityriasis-versicolor":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,5,0,[8,43,66,87,116],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":28,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":4},"100629169","phase-4-mycological-efficacy-and-safety-of-ketoconazole-2-shampoo-with-a-seven-day-versus-three-day-treatment-duration-in-pityriasis-versicolor-100629169",false,"NCT07471178","Mycological Efficacy and Safety of Ketoconazole 2% Shampoo With a Seven-Day Versus Three-Day Treatment Duration in Pityriasis Versicolor","Mycological Efficacy and Safety of Ketoconazole 2% Shampoo With a Seven-Day Versus Three-Day Treatment Duration in Pityriasis Versicolor: A Double-Blind Randomized Clinical Trial","Inclusion Criteria:\n\n* Male and female patients aged 12 years or older\n* Patients with pityriasis versicolor confirmed mycologically by the presence of short hyphae and round spores on direct microscopic examination using potassium hydroxide (KOH) preparation and Parker Blue-Black® ink\n* Patients who are willing to participate in the study and provide written informed consent after receiving adequate explanation of the study; informed assent is obtained for participants younger than 18 years\n* Participants younger than 18 years who have written permission from a parent or legal guardian\n\nExclusion Criteria:\n\n* Patients in an immobilized condition\n* Patients with pityriasis versicolor lesions limited exclusively to the face, without involvement of other body areas\n* History of hypersensitivity to ketoconazole\n* Use of systemic antifungal agents or systemic corticosteroids within one month prior to study enrollment\n* Use of topical antifungal agents or topical corticosteroids within two weeks prior to study enrollment\n* Patients with severe immunosuppression\n* Pregnant or breastfeeding women",true,"ALL","12 Years",{"count":20,"type":21},76,"ESTIMATED","INTERVENTIONAL",[24],"PHASE4","The goal of this clinical study is to find out whether using ketoconazole 2% shampoo for seven days works better than using it for three days in treating pityriasis versicolor. The study will also evaluate the safety of both treatment durations.\n\nThe main questions this study aims to answer are:\n\n* Does treatment with ketoconazole 2% shampoo for seven days result in better mycological efficacy compared with three days of treatment in patients with pityriasis versicolor?\n* Does treatment with ketoconazole 2% shampoo for seven days lead to better clinical improvement compared with three days of treatment?\n* Are there differences in side effects between the seven-day and three-day ketoconazole 2% shampoo treatment regimens?\n* Are there differences in dermoscopic features of pityriasis versicolor before and after treatment with ketoconazole 2% shampoo when used for seven days compared with three days?",[27],"Pityriasis Versicolor",[27,29,30],"Ketoconazole","Mycological Cure","NOT_YET_RECRUITING","2026-03-11",{"date":34,"type":35},"2026-03-13","ACTUAL",{"date":37,"type":21},"2026-02",{"date":39,"type":21},"2026-06",{"name":41,"class":42},"Fakultas Kedokteran Universitas Indonesia","OTHER",{"id":44,"slug":45,"hasResults":11,"nctId":46,"briefTitle":47,"officialTitle":47,"acronym":48,"eligibilityCriteria":49,"healthyVolunteers":11,"sex":17,"minAge":50,"maxAge":51,"enrollmentInfo":52,"targetDuration":4,"studyType":22,"phases":54,"briefSummary":55,"conditions":56,"keywords":57,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":61,"completionDateStruct":62,"leadSponsor":64,"locationsCount":4},"100618557","phase-4-comparison-of-the-efficacy-of-topical-luliconazole-2-cream-vs-topical-ketoconazole-1-cream-in-the-treatment-of-pityriasis-versicolor-100618557","NCT07333170","Comparison of the Efficacy of Topical Luliconazole 2% Cream vs Topical Ketoconazole 1% Cream in the Treatment of Pityriasis Versicolor.","P versicolor","Inclusion Criteria:\n\n* All patients diagnosed with pityriasis versicolor.\n\nExclusion Criteria:\n\n* Immunocompromised patients","18 Years","50 Years",{"count":53,"type":21},86,[24],"Pityriasis versicolor is a common superficial fungal infection caused by Malassezia species, characterized by hypo- or hyper-pigmented scaly patches on the skin. Topical antifungal agents are the mainstay of treatment. Ketoconazole has been widely used; however, newer agents such as luliconazole may offer improved efficacy and shorter treatment duration. This randomized controlled study aims to compare the efficacy and safety of topical luliconazole versus topical ketoconazole in patients with pityriasis versicolor. Treatment response will be assessed clinically and mycologically to determine comparative outcomes.",[27],[48],"2026-01-09",{"date":60,"type":35},"2026-01-12",{"date":37,"type":21},{"date":63,"type":21},"2026-11",{"name":65,"class":42},"PAEC General Hospital, Islamabad",{"id":67,"slug":68,"hasResults":11,"nctId":69,"briefTitle":70,"officialTitle":70,"acronym":4,"eligibilityCriteria":71,"healthyVolunteers":11,"sex":17,"minAge":72,"maxAge":51,"enrollmentInfo":73,"targetDuration":4,"studyType":22,"phases":74,"briefSummary":77,"conditions":78,"keywords":4,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":4},"100618451","phase-1-comparative-efficacy-of-topical-1-clotrimazole-vs-oral-itraconazole-in-the-treatment-of-pityriasis-versicolor-100618451","NCT07331792","Comparative Efficacy of Topical 1% Clotrimazole vs Oral Itraconazole in the Treatment of Pityriasis Versicolor","Inclusion Criteria:\n\n* Age (15-50 years)\n* Both genders\n* Sufferers of Pityriasis versicolor ( Determined by scale , erythema and pruritus)\n\nExclusion Criteria:\n\n* Pt with history of antifungals in last one month\n* Pt on immunosuppressants or steroid therapy\n* Pregnant and lactating women\n* Pt with chronic medical conditions ( Diabetes and hypertension)","15 Years",{"count":53,"type":21},[75,76],"PHASE1","PHASE2","Comparative efficacy of topical 1% clotrimazole vs oral itraconazole in the treatment of pityriasis versicolor -Randomized control trial",[27],"2026-01-05",{"date":60,"type":35},{"date":82,"type":21},"2026-02-02",{"date":84,"type":21},"2026-05-31",{"name":86,"class":42},"Combined Military Hospital Abbottabad",{"id":88,"slug":89,"hasResults":11,"nctId":90,"briefTitle":91,"officialTitle":92,"acronym":4,"eligibilityCriteria":93,"healthyVolunteers":11,"sex":17,"minAge":50,"maxAge":94,"enrollmentInfo":95,"targetDuration":4,"studyType":22,"phases":97,"briefSummary":98,"conditions":99,"keywords":101,"overallStatus":105,"whyStopped":4,"lastUpdateSubmitDate":106,"lastUpdatePostDateStruct":107,"startDateStruct":109,"completionDateStruct":111,"leadSponsor":113,"locationsCount":115},"100495366","phase-1-a-study-of-the-clinical-efficacy-and-safety-of-20-cassia-alata-extract-against-tinea-versicolor-100495366","NCT05730244","A Study of the Clinical Efficacy and Safety of 20% Cassia Alata Extract Against Tinea Versicolor","A Single Arm No-treatment Self-controlled Trial Pilot Study Evaluating the Clinical Efficacy and Safety Profile of 20% Cassia Alata Cream Against Tinea Versicolor","Inclusion Criteria:\n\n* Patients aged 18-89 of either sex\n* Clinical features suggestive of tinea versicolor AND Microscopic confirmation using skin scraping stains with chlorazol black preparation AND\u002FOR Wood's lamp fluorescence\n* No treatment for versicolor in the preceding 4 weeks\n* No contraindications to the application of C.alata cream including\n* No history of allergy to C. alata\n* No history of preservative allergy\n\nExclusion Criteria:\n\n* Age \\\u003C18 or \\>89 years\n* Pregnant females\n* History of hypersensitivity to C. alata or preservative\n* Treatment within 4 weeks prior to enrollment\n* Lesions which do not meet the diagnostic criteria of tinea versicolor","89 Years",{"count":96,"type":21},20,[75],"The goal of this clinical trial is to establish the efficacy of Cassia alata extract as a cream form in treating tinea versicolor (liver spots\u002Fshifting clouds). The main questions the study aims to answer are:• Does the use of this extract help resolve tinea versicolor better than no treatment? Does the use of this cream have significant side effects i.e, is it safe? Participants will be asked to treat a designated area while leaving additional areas untreated. 1-2 finger tip units of cream will be applied to the treatment site twice daily at least 8 hours apart. Participants will attend the trial clinic every 4 weeks for 12 weeks.",[100,27],"Tinea Versicolor",[102,103,104],"Tinea Versicolor,","Cassia alata extract","Pityriasis versicolor","RECRUITING","2025-11-14",{"date":108,"type":35},"2025-11-19",{"date":110,"type":35},"2025-03-01",{"date":112,"type":21},"2026-12-30",{"name":114,"class":42},"The University of The West Indies",1,{"id":117,"slug":118,"hasResults":11,"nctId":119,"briefTitle":120,"officialTitle":120,"acronym":4,"eligibilityCriteria":121,"healthyVolunteers":11,"sex":17,"minAge":50,"maxAge":51,"enrollmentInfo":122,"targetDuration":4,"studyType":22,"phases":124,"briefSummary":125,"conditions":126,"keywords":127,"overallStatus":105,"whyStopped":4,"lastUpdateSubmitDate":130,"lastUpdatePostDateStruct":131,"startDateStruct":133,"completionDateStruct":134,"leadSponsor":136,"locationsCount":115},"100586973","phase-4-comparison-of-efficacy-of-oral-fluconazole-versus-oral-itraconazole-in-the-treatment-of-pityriasis-versicolor-100586973","NCT06922344","Comparison of Efficacy of Oral Fluconazole Versus Oral Itraconazole in the Treatment of Pityriasis Versicolor","Inclusion Criteria:\n\n* All cases of Pityriasis versicolor\n\nExclusion Criteria:\n\n* Patients with history of chronic renal or liver disease, malignancy , or undergoing any kind of chemotherapy or radiotherapy or having cardiac conduction abnormalities.\n* Patients who received any anti-fungal therapy in the last one month.\n* Pregnant or lactating women.",{"count":123,"type":21},106,[24],"This study compares the efficacy of two drugs, namely flucanazole and itraconazole for the treatment of a common fungal infection of skin.",[27],[27,128,129],"Fluconazole","Itraconazole","2025-04-09",{"date":132,"type":35},"2025-04-10",{"date":110,"type":35},{"date":135,"type":21},"2025-12-31",{"name":137,"class":42},"Khyber Teaching Hospital"]